Shanghai Apeiron Biotechnology Co. Ltd. has divulged kinesin-like protein KIF18A inhibitors reported to be useful for the treatment of cancer, inflammatory disorders and Kartagener syndrome (primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback